79 related articles for article (PubMed ID: 26712118)
1. Effects of Neonatal Iron Feeding and Chronic Clioquinol Administration on the Parkinsonian Human A53T Transgenic Mouse.
Billings JL; Hare DJ; Nurjono M; Volitakis I; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
ACS Chem Neurosci; 2016 Mar; 7(3):360-6. PubMed ID: 26712118
[TBL] [Abstract][Full Text] [Related]
2. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
[TBL] [Abstract][Full Text] [Related]
3. Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice.
Finkelstein DI; Hare DJ; Billings JL; Sedjahtera A; Nurjono M; Arthofer E; George S; Culvenor JG; Bush AI; Adlard PA
ACS Chem Neurosci; 2016 Jan; 7(1):119-29. PubMed ID: 26481462
[TBL] [Abstract][Full Text] [Related]
4. Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation.
Carboni E; Tatenhorst L; Tönges L; Barski E; Dambeck V; Bähr M; Lingor P
Neuromolecular Med; 2017 Sep; 19(2-3):309-321. PubMed ID: 28623611
[TBL] [Abstract][Full Text] [Related]
5. Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse.
Lei P; Ayton S; Appukuttan AT; Volitakis I; Adlard PA; Finkelstein DI; Bush AI
Neurobiol Dis; 2015 Sep; 81():168-75. PubMed ID: 25796563
[TBL] [Abstract][Full Text] [Related]
6. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.
Unger EL; Eve DJ; Perez XA; Reichenbach DK; Xu Y; Lee MK; Andrews AM
Neurobiol Dis; 2006 Feb; 21(2):431-43. PubMed ID: 16230020
[TBL] [Abstract][Full Text] [Related]
7. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.
Matsuoka Y; Vila M; Lincoln S; McCormack A; Picciano M; LaFrancois J; Yu X; Dickson D; Langston WJ; McGowan E; Farrer M; Hardy J; Duff K; Przedborski S; Di Monte DA
Neurobiol Dis; 2001 Jun; 8(3):535-9. PubMed ID: 11442360
[TBL] [Abstract][Full Text] [Related]
8. High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein.
Jia F; Song N; Wang W; Du X; Chi Y; Jiang H
Front Aging Neurosci; 2018; 10():97. PubMed ID: 29681846
[TBL] [Abstract][Full Text] [Related]
9. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
[TBL] [Abstract][Full Text] [Related]
10. Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson's disease.
Diwakarla S; Finkelstein DI; Constable R; Artaiz O; Di Natale M; McQuade RM; Lei E; Chai XY; Ringuet MT; Fothergill LJ; Lawson VA; Ellett LJ; Berger JP; Furness JB
Neurogastroenterol Motil; 2020 Mar; 32(3):e13755. PubMed ID: 31709672
[TBL] [Abstract][Full Text] [Related]
11. An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice.
Liu Q; Xu Y; Wan W; Ma Z
J Neural Transm (Vienna); 2018 Feb; 125(2):203-210. PubMed ID: 29218419
[TBL] [Abstract][Full Text] [Related]
12. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.
Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P
Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637
[TBL] [Abstract][Full Text] [Related]
13. Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice.
Rothman SM; Griffioen KJ; Vranis N; Ladenheim B; Cong WN; Cadet JL; Haran J; Martin B; Mattson MP
J Parkinsons Dis; 2013; 3(2):215-29. PubMed ID: 23938351
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates.
Gruden MA; Davydova TV; Narkevich VB; Fomina VG; Wang C; Kudrin VS; Morozova-Roche LA; Sewell RD
Behav Brain Res; 2014 Apr; 263():158-68. PubMed ID: 24480422
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour.
George S; van den Buuse M; San Mok S; Masters CL; Li QX; Culvenor JG
Exp Neurol; 2008 Apr; 210(2):788-92. PubMed ID: 18295208
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.
Zhang X; Xie W; Qu S; Pan T; Wang X; Le W
Biochem Biophys Res Commun; 2005 Jul; 333(2):544-9. PubMed ID: 15950935
[TBL] [Abstract][Full Text] [Related]
17. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
18. The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.
Gerstenberger J; Bauer A; Helmschrodt C; Richter A; Richter F
Behav Brain Res; 2016 May; 304():102-10. PubMed ID: 26880341
[TBL] [Abstract][Full Text] [Related]
19. Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.
Norris EH; Uryu K; Leight S; Giasson BI; Trojanowski JQ; Lee VM
Am J Pathol; 2007 Feb; 170(2):658-66. PubMed ID: 17255333
[TBL] [Abstract][Full Text] [Related]
20. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
